Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytosorbents Corp (NASDAQ:CTSO)

5.05
Delayed Data
As of Aug 30
 0.00 / 0.00%
Today’s Change
3.11
Today|||52-Week Range
8.10
-9.34%
Year-to-Date
No recent news for Cytosorbents Corp.

Today’s Trading

Previous close5.05
Today’s openn.a.
Day’s range-- - --
Volume1,483
Average volume (3 months)59,798
Market cap$125.9M
Dividend yield--
Data as of 08/30/2016

Growth & Valuation

Earnings growth (last year)+74.42%
Earnings growth (this year)-18.18%
Earnings growth (next 5 years)--
Revenue growth (last year)+16.22%
P/E ratioNM
Price/Sales28.93
Price/Book15.31

Competitors

 Today’s
change
Today’s
% change
CDXCChromadex Corp0.000.00%
CDTXCidara Therapeutics ...+0.16+1.41%
MTPMidatech Pharma PLC0.000.00%
LFVNLifeVantage Corp0.000.00%
Data as of 08/30/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$4.8M
Annual profit (last year)-$8.1M
Net profit margin-169.71%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Phillip P. Chan
Chief Operating Officer
Vincent Capponi
Corporate headquarters
Monmouth Junction, New Jersey

Forecasts

Search for Jobs